Lipid nanoparticles (LNPs), composed of ionizable amino lipids, phosphatidylcholines (PC) lipids, and cholesterol, have shown promise as delivery vehicles for therapeutic oligonucleotides in various applications, including cancer immunotherapies, cellular reprogramming, genome editing, and viral vaccines (
